Article Versions Notes

Mazzella A, Orlandi R, Maiorca S, Uslenghi C, Maisonneuve P, Casiraghi M, Bertolaccini L, Spaggiari L. The Role of Adjuvant Chemotherapy in pN1 (IIB/IIIA) NSCLC Patients Who Undergo Pneumonectomy: Is It Still Justified in the Modern Era? Cancers. 2024; 16(17):3041. https://doi.org/10.3390/cancers16173041

Mazzella, Antonio, Riccardo Orlandi, Sebastiano Maiorca, Clarissa Uslenghi, Patrick Maisonneuve, Monica Casiraghi, Luca Bertolaccini, and Lorenzo Spaggiari. 2024. "The Role of Adjuvant Chemotherapy in pN1 (IIB/IIIA) NSCLC Patients Who Undergo Pneumonectomy: Is It Still Justified in the Modern Era?" Cancers 16, no. 17: 3041. https://doi.org/10.3390/cancers16173041

Mazzella, A., Orlandi, R., Maiorca, S., Uslenghi, C., Maisonneuve, P., Casiraghi, M., Bertolaccini, L., & Spaggiari, L. (2024). The Role of Adjuvant Chemotherapy in pN1 (IIB/IIIA) NSCLC Patients Who Undergo Pneumonectomy: Is It Still Justified in the Modern Era? Cancers, 16(17), 3041. https://doi.org/10.3390/cancers16173041